[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:5p13-microduplication-syndrome":3},{"name":4,"total":5,"trials":6,"biomarkers":14,"states":15},"5p13 microduplication syndrome",1,[7],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT07643896","The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment",[],"RECRUITING","2026-08-03T03:32:35.491916Z","2026-06-14T18:39:22.266078Z",[],[]]